This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Unison Pharmaceuticals Pvt. Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Ramesh Shingala: Innovator in Pharmaceutical Compositions
Introduction
Ramesh Shingala is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy and delivery of medications.
Latest Patents
Ramesh Shingala holds a patent for "Orally disintegrating pharmaceutical compositions of apixaban." This invention relates to orally disintegrating pharmaceutical dosage forms of apixaban or a pharmaceutically acceptable salt or prodrug thereof. The patent specifically describes a stable orally disintegrating pharmaceutical composition comprising apixaban and one or more pharmaceutically acceptable excipients. Furthermore, it details an orally disintegrating dosage form that includes apixaban, at least one disintegrating excipient, and optionally one or more pharmaceutically acceptable excipients for the treatment of disorders associated with Factor Xa. He has 1 patent to his name.
Career Highlights
Ramesh Shingala is currently associated with Unison Pharmaceuticals Pvt. Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation has positioned him as a valuable asset to his company and the industry at large.
Collaborations
Ramesh has collaborated with several professionals in his field, including Balvir Singh and Shivang Prajapati. These collaborations have further enhanced his research and development efforts.
Conclusion
Ramesh Shingala's contributions to pharmaceutical innovations, particularly in the area of orally disintegrating compositions, highlight his role as a key inventor in the industry. His work not only advances medical science but also improves patient care through better drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile